Physician profile
Eric H Reed
NPI 1346469079
$4,348.85
in general payments reported to CMS, 2019-2025
8 companies · $505 in 2025
The $505 reported for 2025 was more than what 79% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $223 · 2020: $68.82 · 2021: $78.31 · 2022: $496 · 2023: $607 · 2024: $2,370 · 2025: $505.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,956 · Food and Beverage: $1,526.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,956.21 |
| Food and Beverage | $1,526.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Straumann USA LLC | $3,615.41 | 2019-2025 | |
| Biohorizons Implant Systems INC. | $545.28 | 2019-2025 | Biohorizons, Biohorizons Dental Implants |
| Geistlich Pharma, North America, INC. | $47.78 | 2023-2024 | Geistlich Bio-Gide, Bio-Gide, Bio-Materials |
| Southern Implants North America INC | $47.41 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $31.38 | 2025 | |
| Zimvie INC. | $29.62 | 2023 | |
| Orapharma, A Division of Bausch Health US, LLC | $20.02 | 2024 | Arestin |
| Pacira Pharmaceuticals Incorporated | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Reed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.